USS Investment Management Ltd trimmed its holdings in Amdocs Limited (NASDAQ:DOX - Free Report) by 33.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 22,345 shares of the technology company's stock after selling 11,301 shares during the period. USS Investment Management Ltd's holdings in Amdocs were worth $1,903,000 at the end of the most recent quarter.
Other hedge funds also recently made changes to their positions in the company. Jones Financial Companies Lllp acquired a new stake in shares of Amdocs in the fourth quarter valued at approximately $36,000. SBI Securities Co. Ltd. acquired a new stake in shares of Amdocs in the fourth quarter valued at approximately $41,000. Global Retirement Partners LLC lifted its position in shares of Amdocs by 45.6% in the fourth quarter. Global Retirement Partners LLC now owns 559 shares of the technology company's stock valued at $48,000 after buying an additional 175 shares during the last quarter. Tower Research Capital LLC TRC increased its stake in shares of Amdocs by 55.0% during the fourth quarter. Tower Research Capital LLC TRC now owns 586 shares of the technology company's stock worth $50,000 after purchasing an additional 208 shares during the period. Finally, Private Trust Co. NA increased its stake in shares of Amdocs by 121.5% during the fourth quarter. Private Trust Co. NA now owns 671 shares of the technology company's stock worth $57,000 after purchasing an additional 368 shares during the period. 92.02% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Separately, Wall Street Zen lowered shares of Amdocs from a "strong-buy" rating to a "buy" rating in a report on Friday, February 28th.
View Our Latest Stock Analysis on DOX
Amdocs Price Performance
Shares of NASDAQ DOX traded up $0.99 during mid-day trading on Tuesday, hitting $92.35. 534,384 shares of the stock traded hands, compared to its average volume of 685,254. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.16 and a quick ratio of 1.20. Amdocs Limited has a twelve month low of $74.41 and a twelve month high of $94.61. The company has a market cap of $10.43 billion, a PE ratio of 21.43, a price-to-earnings-growth ratio of 1.47 and a beta of 0.51. The firm has a 50 day simple moving average of $87.92 and a two-hundred day simple moving average of $87.13.
Amdocs (NASDAQ:DOX - Get Free Report) last announced its earnings results on Wednesday, May 7th. The technology company reported $1.78 EPS for the quarter, topping the consensus estimate of $1.71 by $0.07. The firm had revenue of $1.13 billion for the quarter, compared to the consensus estimate of $1.12 billion. Amdocs had a return on equity of 18.89% and a net margin of 10.19%. The business's quarterly revenue was down 9.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.56 EPS. As a group, equities research analysts forecast that Amdocs Limited will post 6.21 EPS for the current fiscal year.
Amdocs Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Monday, June 30th will be given a dividend of $0.527 per share. The ex-dividend date is Monday, June 30th. This represents a $2.11 dividend on an annualized basis and a yield of 2.28%. Amdocs's dividend payout ratio (DPR) is currently 44.21%.
Amdocs Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Further Reading
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
